Goldman Sachs Group »

Aclaris Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $547k 521k 1.05
2023-09-30 $1.9M 273k 6.85
2023-06-30 $4.0M 390k 10.37
2023-03-31 $2.4M 297k 8.09
2022-12-31 $5.5M 347k 15.75
2022-06-30 $5.7M 408k 13.96
2022-03-31 $4.5M 259k 17.24
2021-12-31 $3.2M 221k 14.54
2021-09-30 $7.9M 441k 18.00
2021-03-31 $3.0M 121k 25.20
2020-12-31 $170k 26k 6.46
2020-09-30 $68k 26k 2.58
2020-06-30 $57k 35k 1.62
2019-12-31 $86k 46k 1.88
2019-09-30 $46k 42k 1.09
2019-06-30 $353k 161k 2.19
2019-03-31 $580k 97k 5.99
2018-12-31 $922k 125k 7.39
2018-09-30 $1.4M 95k 14.52
2018-06-30 $1.4M 69k 19.97
2018-03-31 $1.7M 99k 17.52
2017-12-31 $1.8M 72k 24.66
2017-09-30 $6.3M 243k 25.81
2017-06-30 $5.8M 215k 27.12
2017-03-31 $3.9M 130k 29.81